Skip to content

Research on Myocardial Imaging Using a Long-Axial Ultra-High Temporal Resolution PET/CT System

Research on Myocardial Imaging Using a Long-Axial Ultra-High Temporal Resolution PET/CT System

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500101019
Enrollment
Unknown
Registered
2025-04-18
Start date
2025-05-15
Completion date
Unknown
Last updated
2025-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease Coronary Microvascular Disease

Interventions

The group of patients with confirmed coronary heart disease. (Perform myocardial perfusion imaging and 18F-FDG PET/CT myocardial metabolic imaging):NA
The group of patients with clinically suspected coronary microvascular disease (Perform rest and stress 13N-NH3 PET/CT myocardial perfusion imaging):NA

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Participants have provided signed informed consent and expressed willingness to comply with the entire study protocol. 2. Patients aged 18-75 years old, gender is not limited. 3. Patients with clinically suspected coronary microangiopathy, patients with symptoms such as panic, chest pain and chest tightness, and morphological imaging (coronary CT angiography or coronary angiography) is negative or positive but not consistent with symptoms; or patients with clinically confirmed coronary artery disease; 4. Patients who have recent results of electrocardiogram, echocardiogram with cardiac enzymes; 5. Patients consent to undergo myocardial imaging via long-axis ultra-high-resolution PET/CT and are deemed physically capable of tolerating the procedure.

Exclusion criteria

Exclusion criteria: 1. Allergic to the load drugs and tracers used in PET/CT scans. 2. Suffering from severe liver or kidney insufficiency, cardiopulmonary failure, or other serious comorbidities. 3. Pregnant or breastfeeding women. 4. Patients deemed unsuitable for participation in the clinical trial by the researchers.

Design outcomes

Primary

MeasureTime frame
Image quality;

Secondary

MeasureTime frame
absolute myocardial blood flow;area of scarred myocardium;coronary flow reserve;area of viable myocardium;

Countries

China

Contacts

Public ContactXiaoli Lan

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

hzslxl@163.com+86 27 85726685

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026